Skip to main content
Premium Trial:

Request an Annual Quote

Aperiomics Wins $229K NSF Award for Metagenomic Sequencing-Based Pathogen ID Tech

NEW YORK (GenomeWeb) – Aperiomics has been awarded additional Small Business Innovative Research funding from the National Science Foundation, the firm announced today.

The funding, which totals $229,000, will support the further development of the firm's deep metagenomic shotgun sequencing-based test that can be used to identify infectious disease pathogens. The test detects all bacteria, DNA viruses, fungi, and parasites in a single sample, comparing sequencing results to the firm's proprietary database of more than 32,000 microorganism genomes.

Funding will also support improving the ability of the technology to interrogate challenging samples, such as clinical and forensic specimens, the firm said in a statement.

Started as a bioinformatics service provider named NextGen Diagnostics, the Ashburn, Virginia-based firm rebranded as Aperiomics in 2014. It previously received a total of approximately $1.5 million from the NSF, including Phase I and Phase II SBIR awards. Aperiomics also closed a $512,000 round of seed funding last year, led by a network of women angel investors called Pipeline Angels.

As previously reported, the firm offers its pathogen ID test service out of its CLIA- and CAP-certified laboratory, with a cost of $500 and turn-around time of about two weeks.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.